- 1.
Wang JF, Orlow SJ. Keratosis Pilaris and its Subtypes: Associations, New Molecular and Pharmacologic Etiologies, and Therapeutic Options. Am J Clin Dermatol 2018; 19: 733–57. [PubMed][CrossRef]
- 2.
Maghfour J, Ly S, Haidari W et al. Treatment of keratosis pilaris and its variants: a systematic review. J Dermatolog Treat 2022; 33: 1231–42. [PubMed][CrossRef]
- 3.
Sandilands A, O'Regan GM, Liao H et al. Prevalent and rare mutations in the gene encoding filaggrin cause ichthyosis vulgaris and predispose individuals to atopic dermatitis. J Invest Dermatol 2006; 126: 1770–5. [PubMed][CrossRef]
- 4.
Pennycook KB, McCready TA. Keratosis Pilaris. I: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. https://www.ncbi.nlm.nih.gov/books/NBK546708/ Lest 23.7.2022.
- 5.
Fenner J, Silverberg NB. Skin diseases associated with atopic dermatitis. Clin Dermatol 2018; 36: 631–40. [PubMed][CrossRef]
- 6.
Poskitt L, Wilkinson JD. Natural history of keratosis pilaris. Br J Dermatol 1994; 130: 711–3. [PubMed][CrossRef]
- 7.
Gruber R, Sugarman JL, Crumrine D et al. Sebaceous gland, hair shaft, and epidermal barrier abnormalities in keratosis pilaris with and without filaggrin deficiency. Am J Pathol 2015; 185: 1012–21. [PubMed][CrossRef]
- 8.
Marqueling AL, Gilliam AE, Prendiville J et al. Keratosis pilaris rubra: a common but underrecognized condition. Arch Dermatol 2006; 142: 1611–6. [PubMed][CrossRef]
- 9.
Siegel DH, McKenzie J, Frieden IJ et al. Dermatological findings in 61 mutation-positive individuals with cardiofaciocutaneous syndrome. Br J Dermatol 2011; 164: 521–9. [PubMed][CrossRef]
- 10.
Guidry JA, Rees A, Chan AJ et al. Ulerythema ophryogenes and Noonan syndrome. Dermatol Online J 2013; 19: 14. [PubMed][CrossRef]
- 11.
Reddy S, Brahmbhatt H. A Narrative Review on the Role of Acids, Steroids, and Kinase Inhibitors in the Treatment of Keratosis Pilaris. Cureus 2021; 13: e18917. [PubMed][CrossRef]
- 12.
Eckburg A, Kazemi T, Maguiness S. Keratosis pilaris rubra successfully treated with topical sirolimus: Report of a case and review of the literature. Pediatr Dermatol 2022; 39: 429–31. [PubMed][CrossRef]
- 13.
Tiedemann Svendsen M, Bygum A, Hansen LK et al. Faciale angiofibromer ved tuberøs sklerose behandlet med sirolimussalve. Ugeskr Laeger 2013; 175: 2569–70. [PubMed]
- 14.
Dodds M, Tollefson M, Castelo-Soccio L et al. Treatment of superficial vascular anomalies with topical sirolimus: A multicenter case series. Pediatr Dermatol 2020; 37: 272–7. [PubMed][CrossRef]
- 15.
Kechichian E, Jabbour S, El Hachem L et al. Light and Laser Treatments for Keratosis Pilaris: A Systematic Review. Dermatol Surg 2020; 46: 1397–402. [PubMed][CrossRef]
()